Profile of Immune Response During Nasal Challenge with Dermatophagoides Pteronyssinus in Subjects with Allergic Airway Diseases

Overview

Journal J Inflamm (Lond)

Publisher Biomed Central

Date 2024 Nov 1

PMID 39482718

Authors

Laura Tamasauskiene

Brigita Gradauskiene

Affiliations

Soon will be listed here.

Abstract

Background: T lymphocyte helper (Th) 2 plays the main role in pathogenesis of allergic airway diseases (AAD). Recent studies showed that interleukin (IL) 33, Th17 and Th22 also may be involved in allergic inflammation. The aim is to evaluate cytokine level before and after nasal challenge with Dermatophagoides pteronyssinus in patients with AAD.

Methods: Patients with persistent allergic rhinitis (AR) with or without allergic asthma (AA) allergic to house dust mite and healthy individuals underwent nasal challenge with Dermatophagoides pteronyssinus. Measurements of IL-13, IL-17, IL-22 and IL-33 in serum and nasal lavage were performed before, 2 and 22 h after nasal challenge by ELISA.

Results: . Ten patients with AR only, 6 patients with AR and AA and 7 healthy individuals were involved in the study. Serum IL-22 level significantly increased in patients with AR and AA and nasal lavage IL-22 tended to increase in patients with AAD after nasal challenge. Serum IL-13 level tended to increase in patients with AR and AA. IL-13 level in nasal lavage fluid decreased at 22 h after nasal challenge in patients with AR only. IL-17 level in serum and nasal lavage decreased in patients with AAD. Serum IL-33 tended to increase after nasal challenge whereas IL-33 in nasal lavage significantly decreased.

Conclusion: Cytokine profile differs between local and systemic compartments and between patients with allergic rhinitis only and patients with allergic rhinitis and asthma after nasal challenge.

References

Prieto J, Lensmar C, Roquet A, Van der Ploeg I, Gigliotti D, Eklund A . Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med. 2000; 94(8):806-14. DOI: 10.1053/rmed.2000.0826. View

Valls-Mateus M, Marino-Sanchez F, Ruiz-Echevarria K, Cardenas-Escalante P, Jimenez-Feijoo R, Blasco-Lozano J . Nasal obstructive disorders impair health-related quality of life in adolescents with persistent allergic rhinitis: A real-life study. Pediatr Allergy Immunol. 2017; 28(5):438-445. DOI: 10.1111/pai.12724. View

Bullone M, Carriero V, Bertolini F, Folino A, Mannelli A, Di Stefano A . Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma. Eur Respir J. 2019; 54(5). DOI: 10.1183/13993003.00068-2019. View

Blaiss M, Hammerby E, Robinson S, Kennedy-Martin T, Buchs S . The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: A literature review. Ann Allergy Asthma Immunol. 2018; 121(1):43-52.e3. DOI: 10.1016/j.anai.2018.03.028. View

Erin E, Leaker B, Zacharasiewicz A, Higgins L, Williams T, Boyce M . Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge. Allergy. 2005; 60(12):1524-9. DOI: 10.1111/j.1398-9995.2005.00928.x. View

Gour N, Wills-Karp M . IL-4 and IL-13 signaling in allergic airway disease. Cytokine. 2015; 75(1):68-78. PMC: 4532591. DOI: 10.1016/j.cyto.2015.05.014. View

Auge J, Vent J, Agache I, Airaksinen L, Campo Mozo P, Chaker A . EAACI Position paper on the standardization of nasal allergen challenges. Allergy. 2018; 73(8):1597-1608. DOI: 10.1111/all.13416. View

Bae J, Kim J, Kim E, Mo J . The Role of IL-17 in a Lipopolysaccharide-Induced Rhinitis Model. Allergy Asthma Immunol Res. 2017; 9(2):169-176. PMC: 5266111. DOI: 10.4168/aair.2017.9.2.169. View

Berry M, Parker D, Neale N, Woodman L, Morgan A, Monk P . Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol. 2004; 114(5):1106-9. DOI: 10.1016/j.jaci.2004.08.032. View

10.

Kalinauskaite-Zukauske V, Janulaityte I, Januskevicius A, Malakauskas K . Serum levels of epithelial-derived mediators and interleukin-4/interleukin-13 signaling after bronchial challenge with Dermatophagoides pteronyssinus in patients with allergic asthma. Scand J Immunol. 2019; 90(5):e12820. DOI: 10.1111/sji.12820. View

11.

Licari A, Castagnoli R, Denicolo C, Rossini L, Marseglia A, Marseglia G . The Nose and the Lung: United Airway Disease?. Front Pediatr. 2017; 5:44. PMC: 5334318. DOI: 10.3389/fped.2017.00044. View

12.

Campion N, Villazala-Merino S, Thwaites R, Stanek V, Killick H, Pertsinidou E . Nasal IL-13 production identifies patients with late-phase allergic responses. J Allergy Clin Immunol. 2023; 152(5):1167-1178.e12. DOI: 10.1016/j.jaci.2023.06.026. View

13.

Foray A, Dietrich C, Pecquet C, Machavoine F, Chatenoud L, Leite-de-Moraes M . IL-4 and IL-17 Are Required for House Dust Mite-Driven Airway Hyperresponsiveness in Autoimmune Diabetes-Prone Non-Obese Diabetic Mice. Front Immunol. 2021; 11:595003. PMC: 7904896. DOI: 10.3389/fimmu.2020.595003. View

14.

Matsunaga M, Yamauchi P . IL-4 and IL-13 Inhibition in Atopic Dermatitis. J Drugs Dermatol. 2016; 15(8):925-9. View

15.

Marone G, Granata F, Pucino V, Pecoraro A, Heffler E, Loffredo S . The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma. Front Pharmacol. 2019; 10:1387. PMC: 6908970. DOI: 10.3389/fphar.2019.01387. View

16.

Annunziato F, Romagnani C, Romagnani S . The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2014; 135(3):626-35. DOI: 10.1016/j.jaci.2014.11.001. View

17.

Giavina-Bianchi P, Aun M, Takejima P, Kalil J, Agondi R . United airway disease: current perspectives. J Asthma Allergy. 2016; 9:93-100. PMC: 4872272. DOI: 10.2147/JAA.S81541. View

18.

Bagnasco D, Ferrando M, Varricchi G, Passalacqua G, Canonica G . A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma. Int Arch Allergy Immunol. 2016; 170(2):122-31. DOI: 10.1159/000447692. View

19.

Jirmo A, Busse M, Happle C, Skuljec J, Daluge K, Habener A . IL-17 regulates DC migration to the peribronchial LNs and allergen presentation in experimental allergic asthma. Eur J Immunol. 2020; 50(7):1019-1033. DOI: 10.1002/eji.201948409. View

20.

Bayrak Degirmenci P, Aksun S, Altin Z, Bilgir F, Arslan I, Colak H . Allergic Rhinitis and Its Relationship with IL-10, IL-17, TGF-, IFN-, IL 22, and IL-35. Dis Markers. 2018; 2018:9131432. PMC: 5859791. DOI: 10.1155/2018/9131432. View